Smith RN - Search Results

1

Pathology of an islet transplant 2 years after transplantation: evidence for a nonimmunological loss.

Smith RN, Kent SC, Nagle J, Selig M, Iafrate AJ, Najafian N, Hafler DA, Auchincloss H, Orban T, Cagliero E. Smith RN, et al. Transplantation. 2008 Jul 15;86(1):54-62. doi: 10.1097/TP.0b013e318173a5da. Transplantation. 2008. PMID: 18622278

2

Long-term islet allograft function in the absence of chronic immunosuppression: a case report of a nonhuman primate previously made tolerant to a renal allograft from the same donor.

Kawai T, Sogawa H, Koulmanda M, Smith RN, O'Neil JJ, Wee SL, Boskovic S, Sykes M, Colvin RB, Sachs DH, Auchincloss H Jr, Cosimi AB, C Ko DS. Kawai T, et al. Among authors: smith rn. Transplantation. 2001 Jul 27;72(2):351-4. doi: 10.1097/00007890-200107270-00036. Transplantation. 2001. PMID: 11477369

3

Higher frequency of high-grade rejections in cardiac allograft patients after Quilty B lesions or grade 2/4 rejections.

Smith RN, Chang Y, Houser S, Dec GW, Grazette L. Smith RN, et al. Transplantation. 2002 Jun 27;73(12):1928-32. doi: 10.1097/00007890-200206270-00014. Transplantation. 2002. PMID: 12131690

4

The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection.

Abdi R, Smith RN, Makhlouf L, Najafian N, Luster AD, Auchincloss H Jr, Sayegh MH. Abdi R, et al. Among authors: smith rn. Diabetes. 2002 Aug;51(8):2489-95. doi: 10.2337/diabetes.51.8.2489. Diabetes. 2002. PMID: 12145162

5

The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade.

Makhlouf L, Kishimoto K, Smith RN, Abdi R, Koulmanda M, Winn HJ, Auchincloss H Jr, Sayegh MH. Makhlouf L, et al. Among authors: smith rn. Diabetes. 2002 Nov;51(11):3202-10. doi: 10.2337/diabetes.51.11.3202. Diabetes. 2002. PMID: 12401711

6

Pig islet xenografts are resistant to autoimmune destruction by non-obese diabetic recipients after anti-CD4 treatment.

Koulmanda M, Qipo A, Smith RN, Auchincloss H Jr. Koulmanda M, et al. Among authors: smith rn. Xenotransplantation. 2003 Mar;10(2):178-84. doi: 10.1034/j.1399-3089.2003.02040.x. Xenotransplantation. 2003. PMID: 12588650

7

The effect of low versus high dose of streptozotocin in cynomolgus monkeys (Macaca fascilularis).

Koulmanda M, Qipo A, Chebrolu S, O'Neil J, Auchincloss H, Smith RN. Koulmanda M, et al. Among authors: smith rn. Am J Transplant. 2003 Mar;3(3):267-72. doi: 10.1034/j.1600-6143.2003.00040.x. Am J Transplant. 2003. PMID: 12614280 Free article.

8

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice.

Ansari MJ, Salama AD, Chitnis T, Smith RN, Yagita H, Akiba H, Yamazaki T, Azuma M, Iwai H, Khoury SJ, Auchincloss H Jr, Sayegh MH. Ansari MJ, et al. Among authors: smith rn. J Exp Med. 2003 Jul 7;198(1):63-9. doi: 10.1084/jem.20022125. J Exp Med. 2003. PMID: 12847137 Free PMC article.

9

Effects of streptozotocin on autoimmune diabetes in NOD mice.

Koulmanda M, Qipo A, Auchincloss H Jr, Smith RN. Koulmanda M, et al. Among authors: smith rn. Clin Exp Immunol. 2003 Nov;134(2):210-6. doi: 10.1046/j.1365-2249.2003.02293.x. Clin Exp Immunol. 2003. PMID: 14616779 Free PMC article.

10

Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo.

Abdi R, Means TK, Ito T, Smith RN, Najafian N, Jurewicz M, Tchipachvili V, Charo I, Auchincloss H Jr, Sayegh MH, Luster AD. Abdi R, et al. Among authors: smith rn. J Immunol. 2004 Jan 15;172(2):767-75. doi: 10.4049/jimmunol.172.2.767. J Immunol. 2004. PMID: 14707046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

429 results

Search Page